348 related articles for article (PubMed ID: 12569182)
1. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
Stevens A; Garside H; Berry A; Waters C; White A; Ray D
Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182
[TBL] [Abstract][Full Text] [Related]
2. RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor binding.
Schulz M; Eggert M; Baniahmad A; Dostert A; Heinzel T; Renkawitz R
J Biol Chem; 2002 Jul; 277(29):26238-43. PubMed ID: 12011091
[TBL] [Abstract][Full Text] [Related]
3. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
[TBL] [Abstract][Full Text] [Related]
4. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction.
Ronacher K; Hadley K; Avenant C; Stubsrud E; Simons SS; Louw A; Hapgood JP
Mol Cell Endocrinol; 2009 Feb; 299(2):219-31. PubMed ID: 19007848
[TBL] [Abstract][Full Text] [Related]
5. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor.
Zhang X; Jeyakumar M; Petukhov S; Bagchi MK
Mol Endocrinol; 1998 Apr; 12(4):513-24. PubMed ID: 9544987
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressor.
Cheng S; Brzostek S; Lee SR; Hollenberg AN; Balk SP
Mol Endocrinol; 2002 Jul; 16(7):1492-501. PubMed ID: 12089345
[TBL] [Abstract][Full Text] [Related]
7. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain.
Garside H; Stevens A; Farrow S; Normand C; Houle B; Berry A; Maschera B; Ray D
J Biol Chem; 2004 Nov; 279(48):50050-9. PubMed ID: 15355994
[TBL] [Abstract][Full Text] [Related]
9. Corepressor binding to progesterone and glucocorticoid receptors involves the activation function-1 domain and is inhibited by molybdate.
Wang D; Simons SS
Mol Endocrinol; 2005 Jun; 19(6):1483-500. PubMed ID: 15774497
[TBL] [Abstract][Full Text] [Related]
10. Role of steroid receptor coactivators in glucocorticoid and transforming growth factor beta regulation of plasminogen activator inhibitor gene expression.
Li G; Heaton JH; Gelehrter TD
Mol Endocrinol; 2006 May; 20(5):1025-34. PubMed ID: 16423881
[TBL] [Abstract][Full Text] [Related]
11. Structure/function of the human glucocorticoid receptor: tyrosine 735 is important for transactivation.
Ray DW; Suen CS; Brass A; Soden J; White A
Mol Endocrinol; 1999 Nov; 13(11):1855-63. PubMed ID: 10551779
[TBL] [Abstract][Full Text] [Related]
12. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators.
Tagami T; Gu WX; Peairs PT; West BL; Jameson JL
Mol Endocrinol; 1998 Dec; 12(12):1888-902. PubMed ID: 9849963
[TBL] [Abstract][Full Text] [Related]
13. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
Chien PY; Ito M; Park Y; Tagami T; Gehm BD; Jameson JL
Mol Endocrinol; 1999 Dec; 13(12):2122-36. PubMed ID: 10598586
[TBL] [Abstract][Full Text] [Related]
14. The nuclear-receptor interacting protein (RIP) 140 binds to the human glucocorticoid receptor and modulates hormone-dependent transactivation.
Windahl SH; Treuter E; Ford J; Zilliacus J; Gustafsson JA; McEwan IJ
J Steroid Biochem Mol Biol; 1999 Dec; 71(3-4):93-102. PubMed ID: 10659697
[TBL] [Abstract][Full Text] [Related]
15. Bag-1M inhibits the transactivation of the glucocorticoid receptor via recruitment of corepressors.
Hong W; Baniahmad A; Li J; Chang C; Gao W; Liu Y
FEBS Lett; 2009 Aug; 583(15):2451-6. PubMed ID: 19595997
[TBL] [Abstract][Full Text] [Related]
16. Molecular switch in the glucocorticoid receptor: active and passive antagonist conformations.
Schoch GA; D'Arcy B; Stihle M; Burger D; Bär D; Benz J; Thoma R; Ruf A
J Mol Biol; 2010 Jan; 395(3):568-77. PubMed ID: 19913032
[TBL] [Abstract][Full Text] [Related]
17. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
Jackson TA; Richer JK; Bain DL; Takimoto GS; Tung L; Horwitz KB
Mol Endocrinol; 1997 Jun; 11(6):693-705. PubMed ID: 9171233
[TBL] [Abstract][Full Text] [Related]
18. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.
Krogsdam AM; Nielsen CA; Neve S; Holst D; Helledie T; Thomsen B; Bendixen C; Mandrup S; Kristiansen K
Biochem J; 2002 Apr; 363(Pt 1):157-65. PubMed ID: 11903058
[TBL] [Abstract][Full Text] [Related]
19. Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor.
Li Y; Suino K; Daugherty J; Xu HE
Mol Cell; 2005 Aug; 19(3):367-80. PubMed ID: 16061183
[TBL] [Abstract][Full Text] [Related]
20. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions.
Wu J; Li Y; Dietz J; Lala DS
Mol Endocrinol; 2004 Jan; 18(1):53-62. PubMed ID: 14551261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
